In a recent, large clinical trial involving more than 17,000 adults living with overweight or obesity and established heart disease, participants who received a weekly semaglutide injection experienced a 20% reduction in major adverse cardiovascular events (MACE), such as heart attack and stroke, compared to those who didnt take the medication
"If approved, retatrutide will be the first in a new class of medications." Eli Lilly announced results from its phase 3 trial TRIUMPH-4 in December, testing retatrutides effect on weight loss and other health conditions
Appetite suppression intensifies, and the glucagon receptor effects become more pronounced as higher doses are reached
It provides insights into the regulation of skin pigmentation and can serve as a model for studying treatments for hypo- or hyperpigmentation disorders
Staying hydrated, eating smaller frequent meals, and maintaining consistent injection timing all reduce discomfort during escalation